Latest stories on CBLL
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
Business Insider50 · neutralgeneral
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
GlobeNewswire50 · neutralgeneral
Ceribell price target raised to $33 from $29 at TD Cowen
The Fly61 · neutralanalyst
CeriBell: FDA Clearances And Delirium Expansion Could Create A New Growth Driver
Seeking Alpha56 · neutralproduct/pr
Ceribell receives FDA 510k clearance of quantitative EEG trending, analysis
The Fly67 · bullishproduct/pr
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
GlobeNewswire73 · bullishproduct/pr
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
Business Insider68 · bullishproduct/pr
Ceribell stock price target reiterated at $30 by BTIG on growth outlook
Investing.com Analyst Ratings56 · neutralanalyst
BTIG reiterates Ceribell stock rating at buy, $30 price target
Investing.com Analyst Ratings61 · neutralanalyst
Ceribell management to meet with BTIG
The Fly55 · neutralgeneral
Raymond James raises Ceribell stock price target on new growth drivers
Investing.com Analyst Ratings61 · neutralanalyst
Ceribell price target raised to $30 from $28 at BTIG
The Fly61 · neutralanalyst
BTIG raises Ceribell stock price target to $30 on growth outlook
Investing.com Analyst Ratings61 · neutralanalyst
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push
Yahoo Finance63 · neutralproduct/pr
Ceribell’s Revenue Jumps 33% on Strong Account Growth and Robust Margins—Financial Outlook Raised for 2026
August 11, 2026
MarketChameleon73 · bullishearnings
Canaccord raises Ceribell stock price target on strong Q2 results
Investing.com Analyst Ratings61 · neutralanalyst
Ceribell Price Target Raised To 26 From 25 At Canaccord
The Fly61 · neutralanalyst
Ceribell expects $114M-$117M 2026 revenue as CMS finalizes delirium NTAP up to $2,171 per patient
Seeking Alpha73 · bullishearnings
CeriBell, Inc. (CBLL) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
CeriBell (CBLL) Q2 2026 Earnings Call Transcript
The Motley Fool67 · bullishearnings
Ceribell Raises Fy26 Revenue View To 114m 117m From 112m 116m
The Fly63 · neutralearnings
Ceribell Reports Q2 Eps 51c Consensus 46c
The Fly63 · neutralearnings
Ceribell, Inc. (CBLL) files 8-K
SEC 8-K50 · neutralgeneral
Ceribell Reports Second Quarter 2026 Financial Results
StockTitan59 · neutralearnings
Ceribell announces FDA clearance for two new AI algorithm enhancements
The Fly67 · bullishproduct/pr